Alzheimer’s: Immune System Breakthrough
- A novel approach to understanding Alzheimer's disease has revealed a potential key to halting cognitive decline associated with Alzheimer's and other neurodegenerative conditions.
- According to the scientists, blocking STING protected lab mice from mental deterioration.
- John Lukens, director of UVA's Harrison Family Translational Research Center in Alzheimer's and Neurodegenerative Diseases, stated, "Our findings demonstrate that the DNA damage that naturally accumulates during aging...
Groundbreaking research links the STING molecule to Alzheimer’s plaque formation, offering a potential breakthrough in the fight against cognitive decline. University of Virginia (UVA) scientists discovered that blocking STING in mice prevented mental deterioration, pointing to new treatment targets for Alzheimer’s and other neurodegenerative diseases like Parkinson’s and ALS. the immune system’s role in Alzheimer’s is increasingly clear, and this finding opens innovative pathways.News Directory 3 brings you this vital research, explaining how STING may drive harmful inflammation and neuronal damage, key factors in the disease’s progression. The team is focused on developing therapies to regulate STING activity. Discover what’s next in this promising area of research.
New Alzheimer’s Research Targets Immune system for Treatment
Updated June 03, 2025
A novel approach to understanding Alzheimer’s disease has revealed a potential key to halting cognitive decline associated with Alzheimer’s and other neurodegenerative conditions. Researchers at the University of Virginia (UVA) School of Medicine are exploring the possibility that the immune system’s attempts to repair DNA damage in the brain may contribute to Alzheimer’s. Their work indicates that the STING molecule drives the development of harmful plaques and protein tangles,both hallmarks of Alzheimer’s disease. The research team focused on Alzheimer’s disease,neurodegenerative diseases,and the immune system.
According to the scientists, blocking STING protected lab mice from mental deterioration. STING, a crucial component of the brain’s immune system, may also play a importent role in Parkinson’s disease, amyotrophic lateral sclerosis (ALS), dementia, and other conditions that impair memory. Developing therapies to regulate STING activity could offer substantial benefits for patients facing these devastating diagnoses.
Dr. John Lukens, director of UVA’s Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases, stated, ”Our findings demonstrate that the DNA damage that naturally accumulates during aging triggers STING-mediated brain inflammation and neuronal damage in Alzheimer’s disease.” He added that these results help explain the link between aging and increased Alzheimer’s risk,while also identifying a new pathway for treating neurodegenerative diseases. The study highlights the importance of Alzheimer’s research and potential therapeutic interventions.
With over 7 million Americans currently living with Alzheimer’s and projections estimating that number could exceed 13 million by 2050, researchers are urgently seeking ways to better understand and treat the disease. While the exact causes of Alzheimer’s remain unclear, scientists are increasingly recognizing the immune system’s role in it’s development. STING is involved in the immune response, aiding in the removal of viruses and stressed cells containing damaged DNA.
However, STING can become overactive, leading to harmful inflammation and tissue damage. Lukens and his team were keen to determine STING’s role in Alzheimer’s. They discovered that blocking STING activity in lab mice prevented plaque formation, altered the activity of microglia (immune cells), and redirected the function of key genes.
“we found that removing STING dampened microglial activation around amyloid plaques, protected nearby neurons from damage and improved memory function in Alzheimer’s model mice,” said researcher Jessica Thanos, of UVA’s Department of Neuroscience and Center for Brain Immunology and Glia (BIG Center).
Thanos added that the findings suggest STING drives detrimental immune responses in the brain, exacerbating neuronal damage and contributing to cognitive decline in Alzheimer’s disease.
The UVA Health researchers believe that STING is a notably promising target for new treatments because blocking it appears to slow both the accumulation of amyloid plaques and the development of tau tangles, the two leading suspected causes of Alzheimer’s. Other molecules lack this broad involvement and may only be effective during specific stages of the disease.
“We are only beginning to understand the complex role of innate immune activation in the brain, and this is especially true in both normal and pathological aging,” Thanos said.”If we can pinpoint which cells and signals sustain that activation, we will be in a much better position to intervene effectively in disease.”
What’s next
While Lukens’ research has opened new avenues in the fight against Alzheimer’s, further work is needed to translate these findings into effective treatments. Scientists will need to better understand STING’s roles in the body, such as its involvement in the immune system’s response to cancer, to ensure that any new treatment does not cause undesirable side effects. Lukens and his collaborators at the Harrison Family Translational Research Center are focused on addressing these critical questions to accelerate the development of new treatments and, ultimately, a cure for Alzheimer’s.